Oncogenic virus in oral squamous cell carcinoma and the role of oncolytic HSV-1 viro-immunotherapy as an emerging treatment

被引：3
|
作者：
Saravanan, Muthupandian [1 ]
Omole, Richard Kolade [1 ,2 ]
Torimiro, Nkem [2 ]
机构：
[1] Saveetha Inst Med & Tech Sci SIMATS, Saveetha Dent Coll & Hosp, Dept Pharmacol, AMR & Nanotherapeut Lab, Chennai 600077, Tamil Nadu, India
[2] Obafemi Awolowo Univ, Dept Microbiol, Ife 220005, Nigeria
来源：
ORAL ONCOLOGY | 2022年 / 133卷
关键词：
D O I：
10.1016/j.oraloncology.2022.106021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
    Zeng, Jiayi
    Li, Xiangxue
    Sander, Max
    Zhang, Haipeng
    Yan, Guangmei
    Lin, Yuan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [2] ACTIVE IMMUNOTHERAPY Oncolytic Virus Therapy Using HSV-1
    Todo, Tomoki
    GLIOMA: IMMUNOTHERAPEUTIC APPROACHES, 2012, 746 : 178 - 186
  • [3] STEM CELL DELIVERED ONCOLYTIC VIRO-IMMUNOTHERAPY FOR TREATMENT OF GLIOMA AND OVARIAN CANCER: BENCH TO BEDSIDE
    Aboody, K. S.
    Ngai, G.
    Lara, J.
    Curiel, D. T.
    Lesniak, M.
    Portnow, J.
    Mooney, R.
    CYTOTHERAPY, 2024, 26 (06) : S149 - S149
  • [4] Triple-mutated oncolytic HSV-1 armed with IL-12 inhibits bone invasion in oral squamous cell carcinoma
    Uchihashi, Toshihiro
    Kasahara, Shun
    Sugauchi, Akinari
    Matsuda, Takuma
    Kurioka, Kyoko
    Tanaka, Susumu
    Todo, Tomoki
    CANCER SCIENCE, 2023, 114 : 54 - 54
  • [5] An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma
    Gohara, Shunsuke
    Shinohara, Kosuke
    Yoshida, Ryoji
    Kariya, Ryusho
    Tazawa, Hiroshi
    Hashimoto, Masashi
    Inoue, Junki
    Kubo, Ryuta
    Nakashima, Hikaru
    Arita, Hidetaka
    Kawaguchi, Sho
    Yamana, Keisuke
    Nagao, Yuka
    Iwamoto, Asuka
    Sakata, Junki
    Matsuoka, Yuichiro
    Takeshita, Hisashi
    Hirayama, Masatoshi
    Kawahara, Kenta
    Nagata, Masashi
    Hirosue, Akiyuki
    Kuwahara, Yoshikazu
    Fukumoto, Manabu
    Okada, Seiji
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    Nakayama, Hideki
    MOLECULAR THERAPY ONCOLYTICS, 2022, 27 : 141 - 156
  • [6] The role of oncogenic viruses in oral squamous cell carcinoma
    Kolk, Andreas
    MKG-CHIRURG, 2018, 11 (01): : 21 - 29
  • [7] The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
    Uche, Ifeanyi Kingsley
    Kousoulas, Konstantin G.
    Rider, Paul J. F.
    VIRUSES-BASEL, 2021, 13 (07):
  • [8] Novel oncolytic HSV-1 for treatment of slow-growing tumors such as prostate carcinoma
    Takeshima, Y.
    Fukuhara, H.
    Hou, J.
    Homma, Y.
    Ino, Y.
    Todo, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E242 - U668
  • [9] Oncolytic Virus Therapy Using Recombinant HSV-1 for Nonseminoma Germ Cell Tumors
    Kakutani, Shigenori
    Fukuhara, Hiroshi
    Taguchi, Satoru
    Takeshima, Yuta
    Homma, Yukio
    Ino, Yasushi
    Todo, Tomoki
    MOLECULAR THERAPY, 2015, 23 : S131 - S131
  • [10] IMMUNE RESPONSES AFTER INTRAVENOUS TREATMENT WITH ONCOLYTIC HSV-1 IN MICE HARBORING METASTATIC RENAL CELL CARCINOMA
    Tsurumaki, Yuzuri
    Fukuhara, Hiroshi
    Ino, Yasushi
    Kitamura, Tadaichi
    Todo, Tomoki
    JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1170 - 1170
12345